IL33 and chronic myelogenous leukemia, BCR-ABL1 positive: Finally, to assess the functional role of IL-33 and determine if this cytokine regulated the expression of IL-9 and other ILC2-derived cytokines, CML mice were treated with either an anti-ST2 or isotype control antibody.